Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
ACC1 is thought to be the predominant isoform mediating fatty acid synthesis, whereas ACC2, the isoform located near CPT1, is the major regulator of CPT1 activity
323 (Pt 1): 112
Reported Research Benefits Selective GHS-R1a agonism without ACTH, cortisol, or prolactin elevation confirmed in human pharmacology studies Pulsatile GH release: preserves natural GH secretion rhythm (unlike continuous exogenous HGH) Stacked with CJC-1295 DAC: Teichman 2006 showed 210 GH elevation sustained for 911 days Improved body composition: lean mass gain, fat mass reduction in GH secretagogue literature Sleep quality improvement: GH secretion peaks during slow-wave sleep, enhanced by ipamorelin protocols Shorter half-life (~2 hours) allows dosing flexibility and rapid clearance vs long-acting alternatives Dosing Protocol & Reconstitution Reported Research Dosing Not Clinical Recommendations Ipamorelin is most commonly dosed alongside CJC-1295 because the two peptides hit independent receptors (ghrelin and GHRH) and their GH-releasing effects add together
Arch Biochem Biophysics
glucagon receptor activation stimulates -oxidation of fatty acids, reducing hepatic lipid content, while GLP-1 enhances systemic insulin sensitivity and decreases lipolysis in adipose tissue, thereby indirectly reducing hepatic fat influx ( 3.3.3 Anti-inflammatory and anti-fibrotic effects The anti-inflammatory and anti-fibrotic potential of GLP-1 receptor activation has garnered significant attention in the context of liver disease
US$ 20.32
US$ 22.49
US$ 24.98
US$ 21.62
